Tenagrity Solutions, LLC
Tenagrity Solutions, LLC filed a Q2 report for 1DAY Sooner Action Project on July 21, 2025, reporting $30,000 in lobbying income.
Lobbying for 1DAY Sooner Action Project · advocacy organization supporting medical research
-
JENNY CAROLINE DEBERRYPreviously held: Senior Legislative Assistant/ Legislative Assistant, Congressman John J. Duncan, Jr.; Senior Campaign Finance Analyst/ Campaign Finance Analyst, Federal Election Commission
Pandemic and All-Hazards Preparedness and Response Act (PAHPA) and Prescription Drug User Fee Act (PDUFA) and House and Senate FY26 Ag-FDA (S.2256, H.R. 4121), L-HHS appropriations bills (and report language) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA); FDA reforms including maximized use of AI (pursuit of related congressional support letters as well). Support for Sen. Cassidy's anticipated HEP-C elimination legislation (including specifically clinical trial research). Communication with congressional offices re: enabling greater use of human challenge studies. Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries.
Pandemic and All-Hazards Preparedness and Response Act (PAHPA) and Prescription Drug User Fee Act (PDUFA) and House and Senate FY26 Ag-FDA (S.2256, H.R. 4121), L-HHS appropriations bills (and report language) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA); FDA reforms including maximized use of AI (pursuit of related congressional support letters as well). Support for Sen. Cassidy's anticipated HEP-C elimination legislation (including specifically clinical trial research). Communication with congressional offices re: enabling greater use of human challenge studies. Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries.
House and Senate FY26 appropriations bills (L-HHS) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health
Pandemic and All-Hazards Preparedness and Response Act (PAHPA) and Prescription Drug User Fee Act (PDUFA) and House and Senate FY26 Ag-FDA (S.2256, H.R. 4121), L-HHS appropriations bills (and report language) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA); FDA reforms including maximized use of AI (pursuit of related congressional support letters as well). Support for Sen. Cassidy's anticipated HEP-C elimination legislation (including specifically clinical trial research). Communication with congressional offices re: enabling greater use of human challenge studies. Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries. Discussions with the HHS and DoD to support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives
House and Senate FY26 appropriations bills (Ag-FDA: S.2256, H.R. 4121) and NDAA S. 2296 (and report language) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health
House and Senate FY26 appropriations bills (Ag-FDA: S.2256, H.R. 4121) and NDAA S. 2296 (and report language) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health